Vanderbilt-Ingram Cancer Center Archive — Page 13 of 27

Vanderbilt-Ingram website >

The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)
February 9, 2023

Vanderbilt-Ingram joins CancerLinQ quality initiative

Vanderbilt-Ingram Cancer Center is now participating in CancerLinQ, a technology initiative focused on improving patient care that tracks quality metrics in real time.

By Tom Wilemon
February 6, 2023

Berlin named director of Division of Hematology and Oncology

Jordan Berlin, MD, has been named director of Vanderbilt’s Division of Hematology and Oncology.

By Tom Wilemon
January 19, 2023

Surgeons target pancreatic cancer with electrons using new technology

Vanderbilt surgeons recently treated a pancreatic cancer patient using IntraOp Mobetron IORT with electrons — the first surgery performed in Tennessee with this new technology utilizing intraoperative radiotherapy in the operating room.

By Tom Wilemon
January 9, 2023

Novel lung cancer biomarker

Autoantibodies against the p53 tumor suppressor protein may be a novel biomarker for identifying people, especially African Americans, at high risk for lung cancer.

By Leigh MacMillan
January 5, 2023

New approach outperforms existing cancer susceptibility models

A new approach for conducting gene-based analyses for cancer susceptibility created at Vanderbilt outperforms existing models.

By Tom Wilemon
December 8, 2022

Lovly receives Asclepios Award from GO2 for Lung Cancer

Vanderbilt’s Christine Lovly, MD, PhD, has received the 2022 Asclepios Award, which recognizes lung cancer research pioneers.

By Tom Wilemon